Searching for Solutions

No summary available

No summary available

Membership in AAPP brings numerous benefits as listed below. This member toolkit provides you a convenient location to explore information and benefits associated with a AAPP membership.

Psychiatric pharmacists work directly with patients and caregivers to apply specialized clinical knowledge and skills, educate and train healthcare professionals and develop new knowledge in order to improve health outcomes for those individuals with psychiatric disorders, including substance use and neurologic disorders. They apply evidence-based, cost-efficient best practices as a member of a treatment team to achieve patient recovery and improved quality of life.

Shannon Eaves Stratton, PharmD, BCPS, BCPP Mental Health Clinical Pharmacy Practitioner Richard L. Roudebush VA Medical Center Indianapolis, IN

AAPP 2025 industry supported symposia (continuing education) and showcases (non-continuing education) are programs developed for educational purposes. All industry-supported programming at AAPP 2025 is designed for the psychiatric pharmacist and is included in participant registration fees. All symposia are in compliance with Accreditation Council for Pharmacy Education (ACPE) criteria for planning and implementation, and each one provides 1.0 contact hours of ACPE credit.

AAPP details the policy changes needed to enable psychiatric pharmacists to be key professionals helping to bridge care gaps and enhance care integration for people with multiple co-occurring medical and psychiatric conditions and complex medication regimens in both primary care and behavioral health settings. Medicare enhancements, inclusion of psych pharmacists in the collaborative care model, and financial support of PGY2 residencies are among the policy recommendations.

October 2-3, 2025 You are invited to join us for the 5th Annual Summit! The Summit is designed to advance the knowledge and improve competency of participants through the delivery of evidence-based presentations on emerging areas of practice and contemporary issues in psychiatric pharmacy. This two-day, interactive, virtual conference provides knowledge and tools to improve the comprehensive care of patients with mental health disorders.

The American Association of Psychiatric Pharmacists (AAPP) promotes the utilization of evidence-based resources during the development of content for presentations, toolkits, manuscripts, etc. AAPP strives to disseminate information that is fair and balanced, grounded in sound scientific evidence, and aligned with established best practices to support safe, effective patient care.

Classic psychedelics, or classical hallucinogens, are Schedule I psychoactive drugs which historically have been used by various ethnic groups for traditional and religious purposes and associated spiritual experiences. In modern times, psychedelics are commonly used for their recreational intentions.

Several hours have been reserved for discussions on current issues in practice on Sunday, 4/27 through Tuesday, 4/29.

Alcohol and benzodiazepine (BZD) withdrawal are clinical manifestations of the abrupt cessation or reduction in the use of substances which have been used regularly and heavily. Larger quantities and longer durations are associated with greater risk of developing significant alcohol or BZD withdrawal, which can be a medical emergency. Goals of treatment include minimizing and/or preventing the symptoms of withdrawal with a focus on prevention of seizures and delirium tremens (DTs).

Convince Your Supervisor to Support AAPP 2025 Attendance! The merits of the AAPP Annual Meeting are undeniable. Even so, with most organizations having limited travel and education budgets, it may be necessary to show justification when selling your attendance at AAPP 2025.

Virtual Student Opportunities AAPP student members received FREE virtual registration to AAPP 2025! In-Person Student Opportunities For those who attended the event in Salt Lake City, Utah.